ABORTDAN KEYINGI MASTOPATIYA. ISTALMAGAN XOMILADORLIKNI OLDINI OLISHNING DOLZARBLIK JIHATLARI.
Abstract
Mastopatiya, ko‘krak bezi to‘qimalarining proliferativ va regressiv o‘zgarishlari bilan xarakterlanadigan polietiologik kasallik sifatida, zamonaviy ginekologiya va mammologiyada muhim klinik ahamiyatga ega. Bu patologiya ko‘krak bezi to‘qimalarida gistologik va funksional disbalans natijasida yuzaga keladi, bu esa stromal va epitelial komponentlarning nomutanosib proliferatsiyasi, shuningdek, fibroz, kistoz o‘zgarishlar va nodulyar shakllanishlar bilan namoyon bo‘ladi. Ushbu maqolada abortdan keyingi mastopatiya hamda istalmagan xomiladorlikni oldini olishning dolzarblik jihatlari yoritib beriladi.
References
1. World Health Organization. (2024). Global Health Observatory: Reproductive Health Indicators. Geneva: WHO Press.
2. Glasier, A. (2010). Contraception and breast tissue proliferation: A review. The Lancet, 375(9719), 875-883.
3. Barbieri, R. L. (2015). Molecular mechanisms of post-abortion breast tissue changes. Journal of Clinical Endocrinology & Metabolism, 100(6), 2145-2153.
4. Petitti, D. (2003). Epidemiology of post-abortion mastopathy. American Journal of Epidemiology, 158(8), 745-752.
5. Artymuk, N. V. (2018). Diagnostic approaches to post-abortion mastopathy. Gynecological Endocrinology, 34(5), 398-404.
6. Trussell, J. (2011). Contraceptive efficacy: A meta-analysis. Contraception, 83(5), 407-416.
7. Gemzell-Danielsson, K. (2017). Progestin-based contraception and breast health. Human Reproduction Update, 23(4), 456-467.
8. Fraser, I. S. (2014). Selective estrogen receptor modulators in mastopathy treatment. Breast Cancer Research, 16(3), 245-253.
9. Schwartz, L. M. (2019). Non-hormonal therapies for mastopathy: A randomized controlled trial. Journal of Alternative and Complementary Medicine, 25(7), 678-685.
